{"schema_version":"secwatch.filing_event.v1","accession":"0000832101-23-000032","form_type":"8-K","ticker":"IEX","cik":"0000832101","company_name":"IDEX CORP /DE/","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.755043+00:00","generated_at":"2026-06-13T01:35:46.368424+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"IDEX reports record Q2 sales $846M; lowers FY adjusted EPS guidance to $7.90-$8.00 on HST weakness","bullets":["Record Q2 sales $846.2M (+6% overall, +3% organic); reported EPS $1.82, adj. EPS $2.18 (+8%).","FY2023 guidance lowered: organic sales decline 1-2%, GAAP EPS $6.80-$6.90, adj. EPS $7.90-$8.00.","HST segment organic sales -6%, Adj. EBITDA margin -420bps to 27.6%; CEO sees no H2 recovery.","Completed Iridian acquisition for $110.3M cash; issued $100M 5.13% senior notes due 2028.","Operating cash flow $141.2M (+26%), free cash flow $119.6M (+24%)."],"urls":{"canonical":"https://secwatch.observer/filing/0000832101-23-000032","json":"https://secwatch.observer/filing/0000832101-23-000032.json","markdown":"https://secwatch.observer/filing/0000832101-23-000032.md","text":"https://secwatch.observer/filing/0000832101-23-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832101/000083210123000032/0000832101-23-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832101/000083210123000032/iex-20230726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T01:35:46.368424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a97cc0c9bcd9d600e3f8cf7a8585a461dc23f9fa","claim":"IDEX CORP /DE/ reported the three months ended June 30, 2023 results: revenue $846.2 million, net income $138.6 million, EPS $1.82. Guidance lowered.","evidence_excerpt":"IN RESPONSE TO SOFTENING SECOND HALF OUTLOOK Second Quarter 2023 Highlights (All comparisons are against the second quarter of 2022 unless otherwise noted) • Record sales of $846.2 million, up 6% overall and 3% organically • Reported EPS of $1.82, up 1% and record adjusted EPS of $2.18, up 8% • Strong operating cash flow of $141 million, up 26%; free cash flow of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832101/000083210123000032/0000832101-23-000032-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended June 30, 2023"},{"label":"Revenue","value":"$846.2 million"},{"label":"Net income","value":"$138.6 million"},{"label":"EPS","value":"$1.82"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}